Salmon I, Kiss R, Dewitte O, Gras T, Pasteels J L, Brotchi J, Flament-Durand J
Department of Pathology, Erasmus Hospital, Brussels, Belgium.
Cancer. 1992 Jul 15;70(2):538-46. doi: 10.1002/1097-0142(19920715)70:2<538::aid-cncr2820700226>3.0.co;2-#.
The authors studied the benefit of performing histopathologic grading and DNA ploidy characterization with respect to patient survival in a series of 206 astrocytomas (AST) for which they obtained 134 complete clinical follow-ups.
The material analyzed came from archival material, i.e., formalin-fixed paraffin-embedded tissues. DNA ploidy was assessed by means of a cell image processor computing the integrated optical density (IOD) on Feulgen-stained nuclei.
Results showed that histopathologic diagnosis in three grades, i.e., AST, anaplastic astrocytoma (ANA), and glioblastoma multiforme (GBM), had a significant prognostic value. Patients with AST showed a mean survival time (between histopathologic diagnosis and death) of more than 36 +/- 6 months (AST versus ANA or GBM) (P less than 0.001). Patients with ANA and GBM showed a mean survival time of 15 +/- 2 and 10 +/- 1 months, respectively, (ANA versus GBM) (P less than 0.05). Patient age strongly correlated with survival. Patients younger than 40 years of age had a mean survival time of 20 +/- 4 months. Patients between 41 and 60 years of age had a mean survival time of 12 +/- 2 months, and patients older than 60 years of age had a mean survival time of 11 +/- 1 months.
Considering DNA ploidy characterization, the authors noticed that aneuploid ANA (DNA index [DI] more than 1.30) were associated with a significantly higher mean patient survival time compared with that associated with euploid ANA. In contrast, the authors did not find this in either of the groups with AST and GBM. Recognizing six DNA histogram types (diploid, triploid, tetraploid, hyperdiploid, hypertriploid, and polymorphic), the authors observed that hypertriploid tumors were associated with greater patient survival compared with what happened in the cases of the five other DNA histogram types. This was true with respect to the three AST histopathologic types. Thus, DNA ploidy determination seemed helpful in characterizing aggressiveness in adult AST.
作者研究了对206例星形细胞瘤(AST)进行组织病理学分级和DNA倍体特征分析对患者生存的益处,他们获得了其中134例完整的临床随访数据。
分析的材料来自存档材料,即福尔马林固定石蜡包埋组织。通过细胞图像处理器计算Feulgen染色细胞核的积分光密度(IOD)来评估DNA倍体。
结果显示,组织病理学诊断分为三级,即AST、间变性星形细胞瘤(ANA)和多形性胶质母细胞瘤(GBM),具有显著的预后价值。AST患者的平均生存时间(从组织病理学诊断到死亡)超过36±6个月(AST与ANA或GBM相比)(P<0.001)。ANA和GBM患者的平均生存时间分别为15±2个月和10±1个月(ANA与GBM相比)(P<0.05)。患者年龄与生存密切相关。年龄小于40岁的患者平均生存时间为20±4个月。年龄在41至60岁之间的患者平均生存时间为12±2个月,年龄大于60岁的患者平均生存时间为11±1个月。
考虑到DNA倍体特征,作者注意到非整倍体ANA(DNA指数[DI]大于1.30)与整倍体ANA相比,患者平均生存时间显著更长。相比之下,作者在AST和GBM组中均未发现此现象。识别出六种DNA直方图类型(二倍体、三倍体、四倍体、超二倍体、超三倍体和多态性)后,作者观察到超三倍体肿瘤与其他五种DNA直方图类型的病例相比,患者生存率更高。对于三种AST组织病理学类型均如此。因此,DNA倍体测定似乎有助于表征成人AST的侵袭性。